TY - JOUR T1 - Vaginal sarcoma: the Royal Marsden experience JF - International Journal of Gynecologic Cancer JO - Int J Gynecol Cancer SP - 337 LP - 341 DO - 10.1046/j.1525-1438.1994.04050337.x VL - 4 IS - 5 AU - H. Y.S. Ngan AU - J. H. Shepherd AU - C. Fisher AU - P. Blake Y1 - 1994/08/01 UR - http://ijgc.bmj.com/content/4/5/337.abstract N2 - Six patients with vaginal sarcoma are reported here. This clinicopathologic review confirms the poor prognosis of this disease. However, there were three 5-year survivors, all of whom had early stage disease and low to intermediate grade tumors. Apart from tumor grade, stage was of prognostic importance. Late recurrences at 5 and 21 years were noted in two of the three 5-year survivors. Neither chemotherapy nor radiotherapy were of use in the treatment of late stage or recurrent disease. ER -